|
1
|
Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients.
|
PLoS Med
|
2012
|
4.69
|
|
2
|
Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.
|
J Gastroenterol Hepatol
|
2007
|
2.93
|
|
3
|
Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients.
|
Eur Respir J
|
2013
|
1.75
|
|
4
|
Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis.
|
Eur Respir J
|
2013
|
1.58
|
|
5
|
Clinical relevance of Mycobacterium szulgai in The Netherlands.
|
Clin Infect Dis
|
2008
|
0.93
|
|
6
|
Evaluation of co-trimoxazole in the treatment of multidrug-resistant tuberculosis.
|
Eur Respir J
|
2012
|
0.93
|
|
7
|
Mycobacterium xenopi clinical relevance and determinants, the Netherlands.
|
Emerg Infect Dis
|
2008
|
0.87
|
|
8
|
Mycobacterium noviomagense sp. nov.; clinical relevance evaluated in 17 patients.
|
Int J Syst Evol Microbiol
|
2009
|
0.86
|
|
9
|
[Nontuberculous mycobacteria: clinically relevant].
|
Ned Tijdschr Geneeskd
|
2010
|
0.77
|
|
10
|
Impact of new American Thoracic Society diagnostic criteria on management of nontuberculous mycobacterial infection.
|
Am J Respir Crit Care Med
|
2007
|
0.75
|
|
11
|
[A sore throat: tumour, tuberculosis or both?].
|
Ned Tijdschr Geneeskd
|
2015
|
0.75
|